April 14, 2016

DSN examines chain pharmacy, including in-depth coverage of specialty pharmacy, orphan drugs and biosimilars, in this multi-page report.


April 13, 2016

Biologic medications — nine of which were among the Food and Drug Administration’s approvals in 2015 — constitute a big portion of the specialty market.

April 13, 2016

In the last two years, the FDA has broken its record for the approval of orphan drugs to treat diseases that affect 200,000 or fewer people.

April 13, 2016

In this issue, Drug Store News previews its DSN 2016 Yearbook, featuring our annual PoweRx company profiles. The full report will be available this summer with exclusive company rankings and profiles of every company in our Top 50. Two strong examples are Ritzman Pharmacy and Benzer Pharmacy — two small chains that are big on innovation and growing their businesses in unique ways.

April 13, 2016

It’s no secret that the category of drugs drawing the most attention — and money — in recent years has been specialty pharmacy.

April 11, 2016

AbbVie’s Venclexta received priority review, accelerated approval and the breakthrough therapy designation from the FDA. 

April 8, 2016

With the new name, Asembia plans to continue expanding on its specialty pharmaceutical offerings, including solutions for pharmacies, pharmaceutical and biotech companies and payers.

April 6, 2016

The combined company would bring to market oncology therapies, men’s and women’s health therapeutics and consumer health products. 

April 6, 2016

Hospira, now a Pfizer company, entered into an agreement with Celltrion and Celltrion Healthcare in 2009 for several potential biosimilar products, including the recently-approved Inflectra.

April 5, 2016

The accreditation program evaluated CVS Specialty based on such organizational standards as pharmacy care, pharmacy operations and specialty drug and patient management, as well as   the company’s customer service, communications and disclosure standards. 

April 5, 2016
Diplomat will be dispensing Eli Lilly and Co.’s recently approved plaque psoriasis treatment as part of a limited-distribution network. 
April 5, 2016

The partnership is aimed at accelerating several of CutisPharma's products in development toward FDA approval. 

April 5, 2016

Descovy has a similar antiviral efficacy to Gilead’s Viread (tenofovir disoproxil fumarate), but contains one-tenth the dose of tenofovir as Viread, the company said. 

April 4, 2016

Nimbus Apollo’s development program includes a lead candidate for an ACC inhibitor to treat the liver disease non-alcoholic steatohepatitis (NASH), which affects up to 15 million people in the U.S.

April 4, 2016

McKesson has closed its $1.2 billion acquisitions of Biologics and Vantage Oncology, which the company had announced in February. 

March 31, 2016
The FDA granted priority review status to Defitelio and it received an orphan drug designation. The injectable drug’s distribution is expected to being within a week. 
March 29, 2016

By 2020, the biosimilars market will grow to $390 billion and the patents on eight biologic drugs will expire.

March 28, 2016

The fifth edition of this special Rx-Impact report — inserted in headquarter copies of this issue of DSN and delivered to all current members of the U.S. House of Representatives and Senate — is meant to help educate lawmakers on the important role community pharmacy plays as the face of health care in neighborhoods all across America, helping to lower the cost of health care, improving patient access, advancing the quality of care and ultimately delivering better outcomes.

March 25, 2016

With the ability to share information with healthcare practitioners or family members, CareKit apps help people take a more active role in their health.

March 23, 2016

Taltz uses an antibody to bind to an inflammation-causing protein, inhibiting the inflammatory response that can contribute to plaque psoriasis development. 

March 21, 2016

The drug launch marks the first product Teligent is rolling out from its portfolio of withdrawn and discontinued drug applications that the company acquired from AstraZeneca in 2014. 

March 17, 2016

As new blood cancer therapies come to market and patients are able to manage their disease with oral medications at home, Walgreens Specialty Pharmacy pharmacists are well-positioned on the front lines.

March 15, 2016
The average price for branded drugs rose 16.2% in 2015, with a third of branded product seeing a price hike last year, according to Express Scripts. 
March 15, 2016

Like a powerful tide that gradually eats away at the foundations of a once-impregnable sea wall, the booming market for generic drugs advances and recedes with the rise and fall in the number of branded drug patent expirations each year. Download the full Generic Drug Report 2016 to read more.